A detailed history of Nbc Securities, Inc. transactions in Moderna, Inc. stock. As of the latest transaction made, Nbc Securities, Inc. holds 577 shares of MRNA stock, worth $21,262. This represents 0.0% of its overall portfolio holdings.

Number of Shares
577
Previous 601 3.99%
Holding current value
$21,262
Previous $71,000 46.48%
% of portfolio
0.0%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

SELL
$63.64 - $125.14 $1,527 - $3,003
-24 Reduced 3.99%
577 $38,000
Q2 2024

Jul 10, 2024

SELL
$101.21 - $166.61 $55,969 - $92,135
-553 Reduced 47.92%
601 $71,000
Q1 2024

Apr 05, 2024

SELL
$85.37 - $115.44 $5,805 - $7,849
-68 Reduced 5.56%
1,154 $122,000
Q4 2023

Feb 07, 2024

BUY
$69.51 - $104.43 $14,249 - $21,408
205 Added 20.16%
1,222 $121,000
Q3 2023

Nov 03, 2023

BUY
$96.41 - $126.61 $98,048 - $128,762
1,017 New
1,017 $105,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Nbc Securities, Inc. Portfolio

Follow Nbc Securities, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nbc Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Nbc Securities, Inc. with notifications on news.